Acute respiratory failure due to Gemcitabine-induced pulmonary toxicity;Pneumopathie d'hypersensibilité à la Gemcitabine s'accompagnant d'insuffisance respiratoire aiguë

Revue des Maladies Respiratoires

Volumn 19, Issue 2 I, 2002, Pages 253-256

  Stern, J B ^a   Caliandro, R ^a   Lamer, C ^a   Lenoir, S ^a   Theodore C ^b   Grunenwald, D ^a   Girard, P ^a  

^a INSTITUT MUTUALISTE MONTSOURIS   (France)

^b INSTITUT GUSTAVE ROUSSY   (France)

Author keywords

Acute respiratory failure; Bladder cancer; Gemcitabine; Hypersensitivity pneumonia; Interstitial pneumonia

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; GEMCITABINE; METHOTREXATE; PLATINUM DERIVATIVE; PREDNISONE; TAXANE DERIVATIVE; VINBLASTINE; ANTINEOPLASTIC ANTIMETABOLITE; DEOXYCYTIDINE; DRUG DERIVATIVE;

ACUTE RESPIRATORY FAILURE; ADULT; AGED; ALLERGIC PNEUMONITIS; ARTICLE; AUTOPSY; BLADDER CANCER; CANCER; CANCER CHEMOTHERAPY; CASE REPORT; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; DISEASE SEVERITY; DRUG INDUCED DISEASE; DYSPNEA; FEMALE; HUMAN; INTERSTITIAL PNEUMONIA; LUNG CANCER; LUNG LAVAGE; LUNG TOXICITY; MALE; OVARY CANCER; PANCREAS CANCER; THORAX RADIOGRAPHY; URINARY TRACT CANCER; ACUTE DISEASE; CHEMICALLY INDUCED DISORDER; RESPIRATORY FAILURE; RESPIRATORY TRACT ALLERGY; REVIEW;

ACUTE DISEASE; AGED; AGED, 80 AND OVER; ANTIMETABOLITES, ANTINEOPLASTIC; DEOXYCYTIDINE; HUMANS; MALE; RESPIRATORY HYPERSENSITIVITY; RESPIRATORY INSUFFICIENCY;

EID: 0036263250     PISSN: 07618425     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Severe pulmonary toxicity in patients treated with a combination of docetaxel and gemcitabine for metastatic transitional cell carcinoma
2. Severe non-haematological toxicity after treatment with gemcitabine
3. Drug-induced pneumopathies accompanied by acute respiratory insufficiency
4. Successful treatment of gemcitabine toxicity with a brief course of oral corticosteroid therapy
5. Fatal pulmonary toxicity resulting from treatment with gemcitabine
6. Side effects of chemotherapy. Case 3. Acute interstitial pneumonitis related to gemcitabine
7. A Phase I trial of the farnesyl transferase inhibitor SCH66336: Evidence for biological and clinical activity
8. Chemotherapy-induced noncardiogenic pulmonary edema related to gemcitabine plus docetaxel combination with granulocyte colony-stimulating factor support
9. Sudden cardiopulmonary toxicity following a single infusion of gemcitabine
10. Fatal pulmonary toxicity resulting from treatment with gemcitabine
11. Diffuse alveolar damage in a patient treated with gemcitabine